Wu, Qinglong http://orcid.org/0000-0003-3473-075X
Boonma, Prapaporn http://orcid.org/0000-0001-7467-839X
Badu, Shyam
Yalcinkaya, Nazli
So, Sik Yu http://orcid.org/0000-0003-2701-0084
Garey, Kevin W.
Williams, Kent
Arnold, L. Eugene http://orcid.org/0000-0002-0886-0692
Shulman, Robert J.
Kellermayer, Richard
Savidge, Tor C. http://orcid.org/0000-0001-5716-5357
Article History
Received: 24 March 2023
Accepted: 20 July 2023
First Online: 3 August 2023
Competing interests
: T.C.S. received research funding from Merck, Nivalis, Cubist, Mead Johnson, Rebiotix, BioFire, Assembly BioSciences, and has served on the advisory board for Rebiotix and BioFire. K.W.G received research funding from Acurx, Paratek, and Seres Health. The remaining authors disclose no conflicts.